Analytical Overview: ORIC Pharmaceuticals Inc (ORIC)’s Ratios Tell a Financial Story

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, ORIC Pharmaceuticals Inc’s stock clocked out at $9.52, down -0.21% from its previous closing price of $9.54. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 0.56 million shares were traded. ORIC stock price reached its highest trading level at $9.67 during the session, while it also had its lowest trading level at $9.44.

Ratios:

To gain a deeper understanding of ORIC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.08 and its Current Ratio is at 15.08. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $20.

On September 22, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $8.Wedbush initiated its Outperform rating on September 22, 2023, with a $8 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’24 when Chacko Jacob sold 40,000 shares for $16.21 per share. The transaction valued at 648,380 led to the insider holds 728,544 shares of the business.

Chacko Jacob sold 26,042 shares of ORIC for $320,186 on Feb 07 ’24. The PRESIDENT AND CEO now owns 768,544 shares after completing the transaction at $12.29 per share. On Feb 06 ’24, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 13,958 shares for $12.12 each. As a result, the insider received 169,160 and left with 794,586 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 671564608 and an Enterprise Value of 394895360.

Stock Price History:

Over the past 52 weeks, ORIC has reached a high of $16.65, while it has fallen to a 52-week low of $5.34. The 50-Day Moving Average of the stock is -2.75%, while the 200-Day Moving Average is calculated to be -6.45%.

Shares Statistics:

It appears that ORIC traded 467.74K shares on average per day over the past three months and 325100 shares per day over the past ten days. A total of 54.87M shares are outstanding, with a floating share count of 46.01M. Insiders hold about 34.77% of the company’s shares, while institutions hold 65.92% stake in the company. Shares short for ORIC as of 1727654400 were 12262863 with a Short Ratio of 26.22, compared to 1724976000 on 12666065. Therefore, it implies a Short% of Shares Outstanding of 12262863 and a Short% of Float of 17.65.

Most Popular